# 99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors

> **NCT06438705** · — · RECRUITING · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 20 (estimated)

## Conditions studied

- Head and Neck Tumor
- Lung Cancer
- Pancreatic Cancer

## Interventions

- **DIAGNOSTIC_TEST:** SPECT-CT imaging

## Key facts

- **NCT ID:** NCT06438705
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06438705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06438705, "99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06438705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*